Semnur Pharmaceuticals Stock Price, News & Analysis
Company Description
Semnur Pharmaceuticals (OTC Link: SMNRW) is a publicly traded company.
SMNRW stock has declined 92.0% over the past year. Shares last traded at $0.0800.
On a trailing twelve-month basis, Semnur Pharmaceuticals reported net income of -$160.4M and diluted earnings per share of $-0.78.
This page provides a comprehensive overview of SMNRW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNRW) stock last traded at $0.0800. Over the past 12 months, the stock has lost 92.0%.
Latest News
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-K, 1 Form S-1/A, 1 Form 10-Q. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNRW SEC filings →
Financial Highlights
operating income reached -$160.4M, and net income was -$160.4M. Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNRW) currently stands at 3.0 thousand shares.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNRW) currently stands at 1.1 days, up 11% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.9 days.